Skip to main content

Table 3 Monitoring of PPMVs in the previous six months by regulatory agencies

From: The potential role of patent and proprietary medicine vendors’ associations in improving the quality of services in Nigeria’s drug shops

 

Oyo

Bayelsa

Total

Ibarapa East

N (%)

Kajola

N (%)

Total

Brass

N (%)

Ogbia

N (%)

Total

At least one monitoring visit

38 (95.0)

39 (97.5)

77 (96.3)

32 (80.0)

23 (57.5)

55 (68.8)

132 (82.5)

By agency

 LGA PPMV association

30 (75.0)

38 (95.0)

68 (85.5)

25 (62.5)

17 (42.5)

42 (52.5)

110 (68.8)

 NAFDAC

16 (40.0)

14 (35.0)

30 (37.5)

14 (35.0)

14 (35.0)

28 (35.0)

58 (36.3)

 PCN

30 (75.0)

11 (27.5)

41 (51.3)

1 (2.5)

5 (12.5)

6 (7.5)

47 (29.4)

 NDLEA

16 (40.0)

18 (45.0)

34 (42.5)

9 (22.5)

5 (12.5)

14 (17.5)

48 (30.0)

 State PPMV association

10(25.0)

13(32.5)

23 (28.8)

2 (5.0)

2 (5.0)

4 (5.0)

27 (16.9)

 State Ministry of Health

14(35.0)

12 (30.0)

26 (32.5)

7 (17.5)

0 (0.0)

7 (8.8)

33 (20.6)

Others

13 (32.5)

14 (35.0)

27 (33.8)

1 (2.5)

2 (5.0)

3 (3.8)

30 (37.5)